폴 헤이스팅스, 에스디바이오센서와 SJL파트너스의 메리디안 바이오사이언스 인수 자문

February 08, 2023

Paul Hastings LLP advised SD Biosensor and SJL Partners in their acquisition of Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials. Meridian stock will no longer be traded on the NASDAQ Global Select Market and its shareholders will have the right to receive $34 per share. The company will continue to operate as an independent entity. The transaction closed on January 31, 2023.

The deal has been shortlisted for Cross-Border M&A Deal of the Year at Law.com International’s Asia Legal Awards 2023.

Corporate partners 

 and  led the Paul Hastings team, which also included associates , and .

The team was supported by Regulatory and Enforcement partner 

; Regulatory and Enforcement associates  and Hanna Ali; Antitrust partners  and ; Antitrust associates  and ; Tax partner ; Employee Benefits partner ; Employee Benefits associate ; IP partner ; IP associates  and ; Finance partner ; Finance associates  and ; Litigation partner ; Capital Markets of counsel ; Capital Markets associate ; Real Estate partners  and ; Real Estate associate ; Privacy and Data Security associate ; Global Trade Controls partner ; Global Trade Controls of counsel ; Global Trade Controls associates  and Ryan Poitras; Anti-Corruption of counsel ; Anti-Corruption associate ; and Private Equity partners  and .

More details on the transaction can be found 


 About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.



Submission Requests

Get in Touch With Us

Contact Us